Chemical Structure (Memantine 01)
Memantine Hydrochloride Tablet, Film Coated
Product Images NDC 0832-1113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 0832-1113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Memantine 02)
Figure 2 (Memantine 03)
This appears to be a graph or chart presenting the percentage of patients compared to the ADCS-ADL change from baseline. The data seems to be separated using a placebo and memantine, with a range of -10 to 20%. Further context is needed to fully understand the purpose and implications of the data presented.*
Figure 3 (Memantine 04)
Figure 4 (Memantine 05)
This is a graph showing the cumulative percentage of patients on placebo and memantine based on their SIB (Severe Impairment Battery) score change from baseline. The x-axis represents the SIB change, and the y-axis represents the cumulative percentage of patients. Unfortunately, there is not enough information to interpret the graph.*
Figure 5 (Memantine 06)
Figure 6 (Memantine 07)
Figure 7 (Memantine 08)
Figure 8 (Memantine 09)
This appears to be a graph that is showing the cumulative percentage of patients in a study. There are two treatment groups, one with placebo/donepezil and another with memantine/donepezil. The horizontal axis is not legible, but the vertical axis shows percentages ranging from 3% to 85%. There is also a reference to a measurement called SIB Chanae, which seems to be a measure of cognitive performance. Without more context, it is difficult to provide a more detailed description.*
Principal Display Panel (5 mg Tablet Bottle Label)
Each tablet of this medication contains 5 mg of Memantine Hydrochloride, with usual adult dosage directions provided in the accompanying full prescribing information. It is recommended to store the medication at a temperature between 20° to 25° Celsius (68° to 77° Fahrenheit), with excursions permitted. The drug is dispensed in a light container kept at a temperature of 25°C as defined by the USP. The medication should be kept out of reach of children. This medication is manufactured by Upsher-Smith Laboratories, LLC, and comes in a bottle of 60 tablets available with a prescription only.*
Principal Display Panel (10 mg Tablet Bottle Label)
Each tablet contains 10 mg of Memantine Hydrochloride, which is typically prescribed for adults. The full prescribing information should be consulted for proper dosage. Store between 20-25°C and keep in a tight container out of reach of children. Manufactured by Upsher-Smith Laboratories, LLC with 60 tablets per prescription. This information may be subject to USP Controlled Room Temperature regulations.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
